Suchergebnisse - (Subject:"Prednisone")

PubPharm (50.851)

21

Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer : Results of part 2 of a randomized phase 2 trial

enthalten in: Cancer | 2024

von McKay, R. | Xie, W. | Yang, X. | +16

22

Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India

enthalten in: Applied health economics and health policy | 2024

von Gupta, N. | Gupta, D. | Vaska, K. | +1

23

New standards of care for treatment of diffuse large B-cell lymphoma

enthalten in: British journal of haematology | 2024

von Abeyakoon, C. | Gregory, G.

24

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

25

Higher risk of hepatotoxicity associated with cabozantinib in cancer patients

enthalten in: Critical reviews in oncology/hematology | 2024

von Wang, Z. | Jiang, L. | Lv, X. | +4

26

Improvement of liver histology in hepatic sarcoidosis due to treatment with corticosteroids and ursodeoxycholic acid : a case report

enthalten in: Clinical journal of gastroenterology | 2024

von Kikuchi, M. | Koizumi, A. | Namisaki, T. | +7

27

Effect of Oral Prednisone on the Prevention and Management of Proliferative Vitreoretinopathy After Open-Globe Injury

enthalten in: Journal of vitreoretinal diseases | 2024

von Yao, T. | Chauhan, M. | Uwaydat, S.

28

Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?

enthalten in: Hematology/oncology clinics of North America | 2024

von Gertz, M.

29

First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC : Applying clinical study findings to clinical practice in the United States

enthalten in: Cancer treatment reviews | 2024

von McKay, R. | Morgans, A. | Shore, N. | +3

30

High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R

enthalten in: Journal of clinical and experimental hematopathology : JCEH | 2024

von Fujimi, A. | Nagamachi, Y. | Yamauchi, N. | +13